INDP Indaptus Therapeutics, Inc.
Healthcare$1.11-9.02%ClosedMarket Cap: $1.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.12
P/S
0.00
EV/EBITDA
-0.03
DCF Value
$8.30
FCF Yield
-808.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-1028.8%
ROA
-864.7%
ROIC
-1396.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-2.2M | $-2.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.2M | $-8.1M | $— | — |
| FY null | $0.00 | NaN% | $-19.8M | $-20.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.6M | $-3.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.5M | $-5.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.6M | $-4.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.2M | $-4.1M | $— | — |
| FY null | $0.00 | NaN% | $-15.4M | $-15.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.1M | $-3.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.1M | $-4.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.9M | $-3.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-4.2M | $-4.0M | $-0.48 | — |